LUGANO, Switzerland, Feb. 24 /PRNewswire-FirstCall/ -- Natural
Alternatives International Europe, S.A., ("NAIE") a wholly owned subsidiary of
Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading
formulator and manufacturer of customized nutritional supplements, is pleased
to announce that the Swissmedic Authority of Bern, Switzerland has granted to
NAIE a pharmaceutical license to process pharmaceuticals for packaging,
importation, export, and sale both in Switzerland and internationally,
effective January 30, 2004. The license will remain valid until January of
2009.
Dr. Fausto Petrini, Managing Director of NAIE stated, "NAIE, operating in
Manno, Switzerland, has primarily focused on non-pharmaceutical nutritional
supplement products since initiating production in September 1999. Obtaining
the pharmaceutical license certifies that our operations conform to Good
Manufacturing Practices. We anticipate this licensure will improve our
ability to develop relationships with new customers."
NAI Chairman of the Board and CEO, Mark A. Le Doux, stated, "Achieving
this milestone of receiving pharmaceutical licensure from the Swiss Federal
government is the result of the leadership of our Swiss and American executive
teams and their combined dedication to providing our customers with the
highest quality manufacturing expertise. I am very proud of Dr. Fausto
Petrini; Randy Weaver, NAI President; Dr. Schwitter, NAIE Quality Assurance
Manager; Mark Zimmerman, NAI Vice President of Operations; and many others on
both sides of the Atlantic who have worked diligently to receive this
license."
NAI, headquartered in San Marcos, California, is a leading formulator and
manufacturer of nutritional supplements that provides strategic partnering
services to its customers. The Company's comprehensive partnership approach
offers a wide range of innovative nutritional products and services to the
client including: scientific research, clinical studies, proprietary
ingredients, customer-specific nutritional product formulation, product
testing and evaluation, marketing management and support, packaging and
delivery system design, regulatory review and international product
registration assistance. For more information about NAI, please see our
website at http://www.nai-online.com.
This press release contains forward-looking statements within the meaning
of Section 21E of the Securities Exchange Act of 1934 that are not historical
facts and information. These statements represent the Company's intentions,
expectations and beliefs concerning future events, including, among other
things, expectations and beliefs with respect to the impact upon future
financial and operating results from the receipt by NAIE of a pharmaceutical
license. The Company wishes to caution readers that these statements involve
risks and uncertainties that could cause actual results and outcomes for
future periods to differ materially from any forward-looking statement or
views expressed herein. The Company's financial performance and the forward-
looking statements contained herein are further qualified by other risks
including those set forth from time to time in the documents filed by the
Company with the Securities and Exchange Commission, including NAI's most
recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K.
For further information please contact: John R. Reaves, Chief Financial
Officer of Natural Alternatives International, Inc., +1-760-744-7340,
info@nai-online.com.
SOURCE Natural Alternatives International, Inc.
 back to top
Related links:
http://www.nai-online.com
CONTACT:
John R. Reaves, Chief Financial Officer of
Natural Alternatives International, Inc., +1-760-744-7340,
info@nai-online.com
|
